Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
The deal makes sense for growth - and for Allergan shareholders - but now the price and uncertainty make this stock hard to swallow.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
Let's look closer at the charts and indicators of ABBV.
AbbVie is dropping on Allergan deal announcement, momentum is weak outside certain pockets.
Does a deal with Eldorado give Caesars all it needs to shift the market share dynamics in the casino industry?
If I am going to tie up money in this deal, it would be only at a significant discount, and only from the ERI side.
I believe a small wager on CZR shares here is worthy of consideration
Let's look at two charts.
The $17 billion acquisition of Caesars by Eldorado is welcomed by activist investor Carl Icahn, who had been pushing Caesars board for a deal.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
Oracle tells investors it can regain the crown it once held among enterprises and end-users, but some aren't so sure.
Tech giant's earnings prove it's a reigning power in the cloud, but now may not be the time to chase the stock.
Is the bad news for Oracle all over?
The bearish alignment of indicators makes Thursday price strength a bit surprising.
Will Slack help set a new trend for IPO strategy among red-hot technology companies?
Adobe bulls may want to keep their excitement in check for the next two to three weeks, as over the past nine out of 10 reports, the stock has moved between 1% and 4% the day after reporting.
Adobe may be eyeing future M&A.
What the latest charts and indicators are telling us after Wednesday night's earnings.
Adobe's leadership position in cloud is clearing the way for share growth and pushing its shares higher despite more conservative guidance from management.
Is Libra the next tectonic shift in tech? Is it even a cryptocurrency at all?
Facebook's first blockchain-backed payment initiative is here. Here's what investors and crypto enthusiasts need to know.
Is breaking up big tech just another big headache?
Investors might be missing the case for Facebook Watch amid the crypto focus. These analysts say they need to keep their eyes on the effort.
Facebook's charts don't look much better than they did earlier this month.
Facebook is fomenting optimism on its blockchain bets, despite traditional cryptocurrency criticism.